Proteomic analysis of Chinese hamster ovary cells.

Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. Nat Biotechnol (2013) 1.36

Advances in Mammalian cell line development technologies for recombinant protein production. Pharmaceuticals (Basel) (2013) 1.12

The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy. Mol Cell Proteomics (2014) 0.89

Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation. Int J Mol Sci (2014) 0.84

CHO microRNA engineering is growing up: recent successes and future challenges. Biotechnol Adv (2013) 0.84

O-GlcNAcomic Profiling Identifies Widespread O-Linked β-N-Acetylglucosamine Modification (O-GlcNAcylation) in Oxidative Phosphorylation System Regulating Cardiac Mitochondrial Function. J Biol Chem (2015) 0.82

Recent advances in cellular glycomic analyses. Biomolecules (2013) 0.80

A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism. Cell Syst (2016) 0.79

Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3). Br J Pharmacol (2014) 0.79

CHOPPI: a web tool for the analysis of immunogenicity risk from host cell proteins in CHO-based protein production. Biotechnol Bioeng (2014) 0.79

Elucidation of the CHO Super-Ome (CHO-SO) by Proteoinformatics. J Proteome Res (2015) 0.78

Analysis of microRNA transcription and post-transcriptional processing by Dicer in the context of CHO cell proliferation. J Biotechnol (2014) 0.78

Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis. MAbs (2015) 0.77

Transcriptome study and identification of potential marker genes related to the stable expression of recombinant proteins in CHO clones. BMC Biotechnol (2015) 0.76

Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles. Iran Biomed J (2015) 0.76

A theoretical estimate for nucleotide sugar demand towards Chinese Hamster Ovary cellular glycosylation. Sci Rep (2016) 0.75

Factors influencing biased agonism in recombinant cells expressing the human α1A -adrenoceptor. Br J Pharmacol (2017) 0.75

Basophile: accurate fragment charge state prediction improves peptide identification rates. Genomics Proteomics Bioinformatics (2013) 0.75

A synthetic biology standard for Chinese Hamster Ovary cell genome monitoring and contaminant detection by polymerase chain reaction. Springerplus (2016) 0.75

Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus. J Biol Chem (2016) 0.75

Proteomic differences in recombinant CHO cells producing two similar antibody fragments. Biotechnol Bioeng (2016) 0.75

What can mathematical modelling say about CHO metabolism and protein glycosylation? Comput Struct Biotechnol J (2017) 0.75

Ribosome profiling-guided depletion of an mRNA increases cell growth rate and protein secretion. Sci Rep (2017) 0.75

Detection and Quantification of ADP-Ribosylated RhoA/B by Monoclonal Antibody. Toxins (Basel) (2016) 0.75

Receptor Quaternary Organization Explains G Protein-Coupled Receptor Family Structure. Cell Rep (2017) 0.75

ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry. MAbs (2017) 0.75

Comparative Proteomic Analysis of Three Chinese Hamster Ovary (CHO) Host Cells. Biochem Eng J (2017) 0.75

Quantifying the Interaction between EGFR Dimers and Grb2 in Live Cells. Biophys J (2017) 0.75

A protein interaction map of Drosophila melanogaster. Science (2003) 20.06

A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20

Codon usage and tRNA content in unicellular and multicellular organisms. Mol Biol Evol (1985) 16.88

Universal sample preparation method for proteome analysis. Nat Methods (2009) 16.88

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A (1986) 15.20

mRNA stability in mammalian cells. Microbiol Rev (1995) 8.78

Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol (2003) 6.98

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol (2003) 6.86

MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis. J Proteome Res (2007) 5.85

Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet (2010) 5.37

Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol (2004) 4.91

A comparison of selected mRNA and protein abundances in human liver. Electrophoresis (1997) 4.35

Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc Natl Acad Sci U S A (2006) 3.71

The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol (1989) 3.69

A high-quality catalog of the Drosophila melanogaster proteome. Nat Biotechnol (2007) 3.34

Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biol (2005) 2.94

The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol (2011) 2.87

Selective charging of tRNA isoacceptors explains patterns of codon usage. Science (2003) 2.81

Biopharmaceutical benchmarks 2010. Nat Biotechnol (2010) 2.80

High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol (2006) 2.74

The role of mRNA and protein stability in gene expression. FASEB J (1989) 2.64

Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3' untranslated region of the mRNA. EMBO J (1989) 2.54

Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics (2011) 2.44

Codon bias as a factor in regulating expression via translation rate in the human genome. Gene (2004) 2.37

Combined transcriptome and proteome analysis as a powerful approach to study genes under glucose repression in Bacillus subtilis. Nucleic Acids Res (2001) 2.28

Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3' end of the mRNA. Proc Natl Acad Sci U S A (1987) 2.26

Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat Protoc (2008) 2.07

Solid-phase extraction of N-linked glycopeptides. Nat Protoc (2007) 2.05

Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol (2002) 1.56

TagRecon: high-throughput mutation identification through sequence tagging. J Proteome Res (2010) 1.49

NetAcet: prediction of N-terminal acetylation sites. Bioinformatics (2004) 1.42

Long-range RNA interaction of two sequence elements required for endonucleolytic cleavage of human insulin-like growth factor II mRNAs. Mol Cell Biol (1995) 1.18

A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. Genome Res (2011) 1.14

Identifying proteomic LC-MS/MS data sets with Bumbershoot and IDPicker. Curr Protoc Bioinformatics (2012) 1.03

Dynamic model of CHO cell metabolism. Metab Eng (2010) 1.03

Genomics and proteomics in process development: opportunities and challenges. Trends Biotechnol (2007) 1.01

Engineering mammalian cells in bioprocessing - current achievements and future perspectives. Biotechnol Appl Biochem (2010) 0.99

Genomic and proteomic exploration of CHO and hybridoma cells under sodium butyrate treatment. Biotechnol Bioeng (2008) 0.97

Using cell engineering and omic tools for the improvement of cell culture processes. Cytotechnology (2007) 0.97

Genomic sequencing and analysis of a Chinese hamster ovary cell line using Illumina sequencing technology. BMC Genomics (2011) 0.93

Context-dependent codon bias and messenger RNA longevity in the yeast transcriptome. Mol Biol Evol (2005) 0.93

Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnol Bioeng (2004) 0.93

Proteomic profiling of a high-producing Chinese hamster ovary cell culture. Anal Chem (2009) 0.92

Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells. Biotechnol J (2008) 0.90

GlycoFly: a database of Drosophila N-linked glycoproteins identified using SPEG--MS techniques. J Proteome Res (2011) 0.88

Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults. Biotechnol Bioeng (2001) 0.86

A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures. Metab Eng (2003) 0.86

Proteomic understanding of intracellular responses of recombinant Chinese hamster ovary cells cultivated in serum-free medium supplemented with hydrolysates. Appl Microbiol Biotechnol (2011) 0.84

Identification of shed proteins from Chinese hamster ovary cells: application of statistical confidence using human and mouse protein databases. Proteomics (2005) 0.84

Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell lines. Biotechnol Bioeng (2010) 0.83

GlycoFish: a database of zebrafish N-linked glycoproteins identified using SPEG method coupled with LC/MS. Anal Chem (2011) 0.83

Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype. BMC Biotechnol (2011) 0.83

Proteomics analysis of chinese hamster ovary cells undergoing apoptosis during prolonged cultivation. Cytotechnology (2011) 0.82

Protein reference mapping of dihydrofolate reductase-deficient CHO DG44 cell lines using 2-dimensional electrophoresis. Proteomics (2010) 0.79

Proteomic studies support the use of multi-product immunoassays to monitor host cell protein impurities. Proteomics (2006) 0.78

Limitations to the comparative proteomic analysis of thrombopoietin producing Chinese hamster ovary cells treated with sodium butyrate. J Biotechnol (2007) 0.78

Development of a highly efficient 2-D system with a serially coupled long column and its application in identification of rat brain integral membrane proteins with ionic liquids-assisted solubilization and digestion. J Proteome Res (2010) 0.76

Human Protein Reference Database--2009 update. Nucleic Acids Res (2008) 21.25

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics (2010) 13.35

A proteomic view of the Plasmodium falciparum life cycle. Nature (2002) 10.65

An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol (2003) 10.46

Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell (2006) 10.10

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature (2011) 8.62

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A (2002) 8.01

Integrating high-throughput and computational data elucidates bacterial networks. Nature (2004) 7.72

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol (2004) 7.69

Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature (2002) 7.38

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell (2011) 7.33

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol (2011) 6.16

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med (2007) 6.01

Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat Protoc (2011) 5.71

Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood (2007) 4.91

Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol (2004) 4.91

MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. Rapid Commun Mass Spectrom (2004) 4.76

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res (2005) 4.61

Proteomic parsimony through bipartite graph analysis improves accuracy and transparency. J Proteome Res (2007) 4.53

Human Plasma PeptideAtlas. Proteomics (2005) 4.52

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. PLoS Med (2007) 4.50

A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol (2012) 4.48

Towards multidimensional genome annotation. Nat Rev Genet (2006) 4.44

Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett (2007) 4.37

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

Genome-scale microbial in silico models: the constraints-based approach. Trends Biotechnol (2003) 4.01

Genome-scale metabolic model of Helicobacter pylori 26695. J Bacteriol (2002) 4.00

Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett (2005) 3.96

IDPicker 2.0: Improved protein assembly with high discrimination peptide identification filtering. J Proteome Res (2009) 3.72

Systems approach to refining genome annotation. Proc Natl Acad Sci U S A (2006) 3.58

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology (2010) 3.57

Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods. Nat Rev Microbiol (2012) 3.56

CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol (2006) 3.49

Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol (2005) 3.46

Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol (2006) 3.39

A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics (2011) 3.37

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology (2007) 3.34

Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal Chem (2003) 3.33

Determination and comparison of the baseline proteomes of the versatile microbe Rhodopseudomonas palustris under its major metabolic states. J Proteome Res (2006) 3.32

Hierarchical thinking in network biology: the unbiased modularization of biochemical networks. Trends Biochem Sci (2004) 3.31

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. J Clin Oncol (2012) 3.28

Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron (2004) 3.16

Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc Natl Acad Sci U S A (2003) 3.15

Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A (2007) 3.12

RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell (2007) 3.09

Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint. Nat Cell Biol (2003) 3.04

Genome-scale reconstruction of metabolic network in Bacillus subtilis based on high-throughput phenotyping and gene essentiality data. J Biol Chem (2007) 3.03

The evolution of molecular biology into systems biology. Nat Biotechnol (2004) 3.00

PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood (2007) 2.93

CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol Cell (2002) 2.92

Context-specific metabolic networks are consistent with experiments. PLoS Comput Biol (2008) 2.90

Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol Cell Proteomics (2002) 2.88

The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol (2011) 2.87

Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res (2006) 2.86

Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Syst Biol (2009) 2.80

Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell (2006) 2.79

Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol (2010) 2.78

Comparison of network-based pathway analysis methods. Trends Biotechnol (2004) 2.78

The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A (2002) 2.77

Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A (2013) 2.75

Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron (2010) 2.75

Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One (2009) 2.68

Navigation with electromagnetic tracking for interventional radiology procedures: a feasibility study. J Vasc Interv Radiol (2005) 2.67

In silico design and adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol Bioeng (2005) 2.63

Metabolic pathways in the post-genome era. Trends Biochem Sci (2003) 2.57

Dicer recognizes the 5' end of RNA for efficient and accurate processing. Nature (2011) 2.49

Control of DNA replication and chromosome ploidy by geminin and cyclin A. Mol Cell Biol (2002) 2.47

Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J Neurosci (2004) 2.45

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol (2006) 2.44

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci U S A (2006) 2.41

Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol Cell Proteomics (2009) 2.39

Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol Cell (2012) 2.38

L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle (2006) 2.37

Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials. Clin Neurophysiol (2007) 2.36

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology (2010) 2.32

The biomass objective function. Curr Opin Microbiol (2010) 2.32

Large-scale evaluation of in silico gene deletions in Saccharomyces cerevisiae. OMICS (2003) 2.31

Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psychiatry (2006) 2.31

Human Proteinpedia: a unified discovery resource for proteomics research. Nucleic Acids Res (2008) 2.30

MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell (2010) 2.29

Structure-specific statistical mapping of white matter tracts. Neuroimage (2008) 2.28

Counting of six pRNAs of phi29 DNA-packaging motor with customized single-molecule dual-view system. EMBO J (2007) 2.21

Reconstruction and functional characterization of the human mitochondrial metabolic network based on proteomic and biochemical data. J Biol Chem (2004) 2.19

Risk factors and prevention of inguinal hernia after radical prostatectomy: a systematic review and meta-analysis. J Urol (2012) 2.17

Characterizing the metabolic phenotype: a phenotype phase plane analysis. Biotechnol Bioeng (2002) 2.14

The anterior cruciate ligament remnant: to leave it or not? Arthroscopy (2013) 2.13

MS/MS networking guided analysis of molecule and gene cluster families. Proc Natl Acad Sci U S A (2013) 2.12

Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. Biophys J (2004) 2.12

Latent pathway activation and increased pathway capacity enable Escherichia coli adaptation to loss of key metabolic enzymes. J Biol Chem (2005) 2.10

Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol Cell Proteomics (2009) 2.09

A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography-mass spectrometry. Mol Cell Proteomics (2005) 2.08

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain (2013) 2.05

Solid-phase extraction of N-linked glycopeptides. Nat Protoc (2007) 2.05

Continuous medial representation for anatomical structures. IEEE Trans Med Imaging (2006) 2.04